77 results
Page 3 of 4
6-K
EX-1.1
98hqaw1wnq0vwwl ytj
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
ovx24irso2 8q1d
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
EX-12.1
qs4c995hqgmn
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
vq7f s2wfvinwny0fv3
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
3h24odmy5imsigy8
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
civq z7sz
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
yndsqcnp
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
4dpcrm
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
kk9ybyx
10 Jul 19
Prospectus supplement
8:18am
F-3
rcp jli8m21qgp74snd
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
facr7uo2wq8kg dpmwy
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.2
umbh7nr4hm
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.3
p46k7kd7 cs78
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.4
5gswizh
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
oecniybf
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.1
y4yslbb
19 Feb 19
Asset Purchase Agreement
4:57pm
6-K
EX-99.2
tpvcoqu0w7jnbk5f4ya
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm